Journal Watch · Journal of Allergy and Clinical Immunology · 2026

Loss of epidermal miR-149 sensitizes to skin inflammation.

Ex vivo delivery of synthetic miR-149 to inflamed skin suppressed inflammatory mediators.<h4>Conclusion</h4>miR-149 acts as a fundamental brake on epithelial-immune interactions, and its loss in AD and psoriasis can lead to amplification of keratinocyte inflammatory responses.

Luo L, Yuan H, Srivastava A et al.Journal of Allergy and Clinical Immunology3 min readPharma relevance 55/100

DOI: 10.1016/j.jaci.2026.06.011PMID: 42362092Study type: preclinical (animal / model) study

TL;DR

Ex vivo delivery of synthetic miR-149 to inflamed skin suppressed inflammatory mediators.<h4>Conclusion</h4>miR-149 acts as a fundamental brake on epithelial-immune interactions, and its loss in AD and psoriasis can lead to amplification of keratinocyte inflammatory responses.

Key findings

  • Single-cell RNA sequencing revealed expansion of activated basal keratinocytes enriched for Tweak-responsive chemokines and immune cell accumulation in Mir149<sup>EKO</sup> skin.
  • Antibody-mediated neutralization of Tweak strongly attenuated enhanced inflammation in vivo.
  • Notably, the miR-149/TWEAKR axis is dysregulated in human psoriasis and AD.
  • Ex vivo delivery of synthetic miR-149 to inflamed skin suppressed inflammatory mediators.<h4>Conclusion</h4>miR-149 acts as a fundamental brake on epithelial-immune interactions, and its loss in AD and psoriasis can lead to amplification of keratinocyte inflammatory responses.

What they did

Chemokine array was performed on keratinocyte supernatants. In mice, in vivo TNF-related weak inducer of apoptosis (Tweak) antibody blockade was performed. Ex vivo skin biopsy samples from patients with psoriasis and allergic contact dermatitis were injected with synthetic miR-149.<h4>Results</h4>Mir149<sup>EKO</sup> mice exhibited a preinflammatory transcriptional state. In both AD and psoriasis models, Mir149<sup>EKO</sup> mice developed exaggerated skin inflammation with epidermal thickening and increased immune infiltration with mast cell accumulation. miR-149 represses the TNF receptor family member Tweakr, and its loss led to enhanced Tweak-induced NF-κB activation and chemokine production.

Full abstract (original)

Background: <h4>Background</h4>Keratinocytes play a central role in amplifying skin inflammation in psoriasis and atopic dermatitis (AD). However, the epithelial-intrinsic regulators involved in responsiveness to inflammatory cues remain poorly defined. MicroRNAs are fundamental regulators of gene expression.<h4>Objective</h4>We sought to define the role of miR-149 in keratinocyte immune functions in healthy skin and chronic inflammatory skin diseases.<h4>Methods</h4>Keratinocyte-specific Mir149-knockout mice (Mir149<sup>EKO</sup>) were generated. Experimental AD (ovalbumin) and psoriasis (IL-23/imiquimod) models were performed, followed by severity scoring, quantitative PCR, RNA sequencing, immunohistochemistry, single-cell RNA sequencing, and flow cytometry.

What they did: Chemokine array was performed on keratinocyte supernatants. In mice, in vivo TNF-related weak inducer of apoptosis (Tweak) antibody blockade was performed. Ex vivo skin biopsy samples from patients with psoriasis and allergic contact dermatitis were injected with synthetic miR-149.<h4>Results</h4>Mir149<sup>EKO</sup> mice exhibited a preinflammatory transcriptional state. In both AD and psoriasis models, Mir149<sup>EKO</sup> mice developed exaggerated skin inflammation with epidermal thickening and increased immune infiltration with mast cell accumulation. miR-149 represses the TNF receptor family member Tweakr, and its loss led to enhanced Tweak-induced NF-κB activation and chemokine production.

Results & conclusions: Single-cell RNA sequencing revealed expansion of activated basal keratinocytes enriched for Tweak-responsive chemokines and immune cell accumulation in Mir149<sup>EKO</sup> skin. Antibody-mediated neutralization of Tweak strongly attenuated enhanced inflammation in vivo. Notably, the miR-149/TWEAKR axis is dysregulated in human psoriasis and AD. Ex vivo delivery of synthetic miR-149 to inflamed skin suppressed inflammatory mediators.<h4>Conclusion</h4>miR-149 acts as a fundamental brake on epithelial-immune interactions, and its loss in AD and psoriasis can lead to amplification of keratinocyte inflammatory responses.

Abstract © the authors / Journal of Allergy and Clinical Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1016/j.jaci.2026.06.011 · PubMed 42362092.

Why it matters for pharma & biotech

  • Relevant to Immunology teams tracking Journal of Allergy and Clinical Immunology for new targets, mechanisms and biomarkers.
  • Because it reports human data, it can inform indication, endpoint and comparator decisions faster than preclinical work.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The work is preclinical. Results in animal or cell models frequently do not translate directly to human efficacy or safety.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Journal of Allergy and Clinical Immunology study find?

Ex vivo delivery of synthetic miR-149 to inflamed skin suppressed inflammatory mediators.<h4>Conclusion</h4>miR-149 acts as a fundamental brake on epithelial-immune interactions, and its loss in AD and psoriasis can lead to amplification of keratinocyte inflammatory responses.

What type of study is this?

It is a preclinical (animal / model) study, published in Journal of Allergy and Clinical Immunology in 2026. Chemokine array was performed on keratinocyte supernatants.

Where can I read the original paper?

The original is at the publisher via DOI 10.1016/j.jaci.2026.06.011. PubMed ID: 42362092. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Luo L, Yuan H, Srivastava A et al.. Loss of epidermal miR-149 sensitizes to skin inflammation.. Journal of Allergy and Clinical Immunology (2026). DOI: 10.1016/j.jaci.2026.06.011.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/loss-of-epidermal-mir-149-sensitizes-to-skin-inflammation-606011/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides